The Serologic Prevalence of SARS-CoV-2 amongst Incarcerated Persons in Provincial Correctional Facilities in Saskatchewan

The primary objective of the study is to ascertain the epidemiological portrait of SARS-CoV-2 among incarcerated adults in a large men’s provincial prison, Regina Provincial Correctional Centre, as a representative surrogate for the overall seroprevalence of SARS-CoV-2 for incarcerated persons across Saskatchewan. The specific objectives are to: * Measure the seroprevalence of SARS-CoV-2 among persons in correctional facilities in Regina; and * Identify the social determinants of health (i.e. socioeconomic status, housing insecurity, etc.) associated with SARS-CoV-2 among people in prison.

Overview

Acronym
SHA
Investigators
Dr. Alexander Wong
Saskatchewan Health Authority
Contacts
Dennaye Fuchs
Saskatchewan Health Authority

General Design

Study design
Cross-sectional
Start - End Year
2021 - 2021
Recruitment Target
  • Individuals
Number of Participants
400
Number of Participants with Biological Samples
400

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Marker Papers

Grzyb, Karolina (2023). The Serologic Prevalence of SARS-CoV-2 Amongst Incarcerated Persons in Provincial Correctional Facilities in Saskatchewan. figshare. Poster. https://doi.org/10.6084/m9.figshare.23971854.v1

Timeline

Population

SHA population
The population is composed of adult males and females incarcerated in both a large men’s provincial prison (Regina Provincial Correctional Centre) and a small women’s remand facility (White Birch Female Remand Unit) in Regina, who are sentenced for less than two years or are awaiting trial. The female participants from the White Birch Remand Centre will be involved if this facility opens during the study period.

Selection Criteria

Countries
  • Canada
Canadian Provinces
  • Saskatchewan
Health Status
  • Exclusion criteria: Anyone in isolation with active SARS-CoV-2 or or under investigation for COVID-19 as a close contact of a diagnosed case; and/or anyone with symptoms compatible with COVID-19.
Other Criteria

Inclusion criteria: Incarcerated at a facility for more than 24 hours; and the ability to understand and consent to study participation.

Exclusion criteria: Anyone posing a security risk to the research team, as determined by correctional officers.

Sources of Recruitment

Specific Population
  • Other specific population : Incarcerated adult male and female
Supplementary Information
Participants were recruited from two selected detention facilities in Regina: Regina Provincial Correctional Centre and White Birch Female Remand Unit.

Sample Size

Number of Participants
400
Number of Participants with Biological Samples
400

Data Collection Events

# Name Data sources Data sources - Biosamples Start End
0 SHA - Data collection
  • Questionnaires
  • Biosamples
  • Blood
2021 (April) 2021 (July)

Participating Studies

Acronym Name Study design Countries

Harmonization Initiatives Included

Acronym Name

Datasets

Name Data Collection Events Variables

Areas of Information Collected

Socio-demographic and economic characteristics
Death
Lifestyle and behaviours
Physical measures and assessments
Birth, pregnancy and reproductive health history
Laboratory measures
Perception of health, quality of life, development and functional limitations
Cognition, personality and psychological measures and assessments
Diseases
Life events, life plans, beliefs and values
Symptoms and signs
Preschool, school and work life
Medication and supplements
Social environment and relationships
Non-pharmacological interventions
Physical environment
Health and community care services utilization
Administrative information

Variables Content Summary

Areas of Information Collected
No Areas of Information Collected
No Scales Collected
Areas of Information Collected per per Population and Data Collection Event
No Areas of Information Collected
No Scales Collected

Networks

Acronym Name Harmonization Initiatives Individual Studies
Last Update: 2024-03-25T16:30:15.306